{
    "Trade/Device Name(s)": [
        "EliA SmDP Immunoassay",
        "EliA\u2122 SmDP Immunoassay"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K183007",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132631"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LKP"
    ],
    "Summary Letter Date": "December 24, 2018",
    "Summary Letter Received Date": "October 31, 2018",
    "Submission Date": "October 31, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies specific for Sm protein"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA-plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Semi-quantitative measurement",
        "Immuno-fluorescence measurement"
    ],
    "Methodologies": [
        "Semi-quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Well"
    ],
    "Document Summary": "FDA 510(k) summary for EliA SmDP Immunoassay on Phadia 2500/5000 instruments for semi-quantitative measurement of IgG antibodies specific for Sm protein.",
    "Indications for Use Summary": "Intended for in vitro semi-quantitative measurement of IgG antibodies to Sm in human serum and EDTA-plasma to aid in the diagnosis of systemic lupus erythematosus (SLE) in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}